Kenneth Atz

Discovery of antimicrobial peptides with notable antibacterial potency by an LLM-based foundation model

Artificial intelligence in drug development

Prospective de novo drug design with deep interactome learning

Leveraging molecular structure and bioactivity with chemical language models for de novo drug design